 In 2007 a new family of triazole NNRTIs was presented by researchers from the pharmaceutical company Ardea Biosciences.The selected candidate from the screening executed was RDEA806 belonging to the family of triazoles.It has similar resistance profile against selected NNRTI resistant HIV-1 strains to other next generation NNRTIs.